Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 4/2014

01-05-2014

Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0

Auteurs: Casilda Olveira, Gabriel Olveira, Francisco Espildora, Rosa-Maria Giron, Gerard Muñoz, Alexandra L. Quittner, Miguel-Angel Martinez-Garcia

Gepubliceerd in: Quality of Life Research | Uitgave 4/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Bronchiectasis is a chronic disease, leading to worsening of health-related quality of life. This study evaluated the psychometric properties of a new patient-reported outcome for non-cystic fibrosis bronchiectasis, the Quality of Life Questionnaire Bronchiectasis, translated into Spanish (QOL-B-Sp-V3.0).

Methods

This prospective study recruited clinically stable patients with non-cystic fibrosis bronchiectasis at 4 Spanish centers. Health status was assessed with multiple indicators (dyspnea, exacerbations, bronchorrhea, etc.), microbiological, radiological, spirometric, and anthropometric parameters plus St-George Respiratory Questionnaire (SGRQ). Psychometric analyses included internal consistency, test–retest reliability, convergent validity, predictive validity, and responsivity to change.

Results

The 207 stable patients (mean age 57.2 years) had a Bhalla score of 11.53 ± 7.39 and FEV1% of 68.3 ± 22.2 %. One hundred and sixty-one stable patients repeated the test 2 weeks later, and 80 patients who had an exacerbation within 6 months of the assessment also repeated it. Internal consistency was high across all scales (Cronbach’s alpha >0.70). Thirty-six of 37 items correlated more strongly with their assigned scale than a competing scale. Test–retest coefficients were strong (intraclass correlations r = 0.68–0.88). All scales, except Treatment Burden, discriminated significantly between patients with mild, moderate, and severe disease according to FEV1% and other respiratory parameters. Strong convergence was found between the QOL-B-Sp-V3.0 and SGRQ. Significant correlations were found between QOL-B-Sp-V3.0 and various clinical, spirometric, radiological, and anthropometric variables. Significant differences were found on all QOL-B-Sp-V3.0 scales, except emotional functioning, between the baseline responses and onset of an exacerbation; robust sensitivity to change was observed on the Respiratory Symptoms scale.

Conclusions

The QOL-B-Sp-V3.0 questionnaire demonstrated strong reliability and validity. Scores were reproducible after 2 weeks, and it discriminated between patients who varied in severity and was responsive to changes related to exacerbation.

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Vendrell, M., de Gracia, J., Olveira, C., et al. (2008). Diagnosis and treatment of bronchiectasis. Recommendations of The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Archivos de Bronconeumologia, 44, 629–640. PubMedCrossRef Vendrell, M., de Gracia, J., Olveira, C., et al. (2008). Diagnosis and treatment of bronchiectasis. Recommendations of The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Archivos de Bronconeumologia, 44, 629–640. PubMedCrossRef
2.
go back to reference Pasteur, M. C., Bilton, D., Hill, A. T., & On behalf of the British Thoracic Society Bronchiectasis (non-CF) Guidelines Group. (2010). British Thoracic Society for non-CF bronchiectasis. Thorax, 65, i1–i58. PubMedCrossRef Pasteur, M. C., Bilton, D., Hill, A. T., & On behalf of the British Thoracic Society Bronchiectasis (non-CF) Guidelines Group. (2010). British Thoracic Society for non-CF bronchiectasis. Thorax, 65, i1–i58. PubMedCrossRef
3.
go back to reference O’Leary, C. J., Wilson, C. B., Hansell, D. M., Cole, P. J., Wilson, R., & Jones, P. W. (2002). Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respiratory Medicine, 96, 686–692. PubMedCrossRef O’Leary, C. J., Wilson, C. B., Hansell, D. M., Cole, P. J., Wilson, R., & Jones, P. W. (2002). Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respiratory Medicine, 96, 686–692. PubMedCrossRef
4.
go back to reference Olveira, C., Olveira, G., Gaspar, I., et al. (2013). Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Quality of Life Research, 22, 597–605. PubMedCrossRef Olveira, C., Olveira, G., Gaspar, I., et al. (2013). Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Quality of Life Research, 22, 597–605. PubMedCrossRef
5.
go back to reference Olveira, G., Olveira, C., Gaspar, I., et al. (2010). Validation of the Spanish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14 + Spain). Archivos de Bronconeumologia, 46, 165–175. PubMed Olveira, G., Olveira, C., Gaspar, I., et al. (2010). Validation of the Spanish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14 + Spain). Archivos de Bronconeumologia, 46, 165–175. PubMed
6.
go back to reference Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. (2005). Development and validation of The Cystic Fibrosis Questionnaire in the United States: A health-related quality-of-life measure for cystic fibrosis. Chest Journal, 128, 2347–2354. CrossRef Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. (2005). Development and validation of The Cystic Fibrosis Questionnaire in the United States: A health-related quality-of-life measure for cystic fibrosis. Chest Journal, 128, 2347–2354. CrossRef
8.
go back to reference Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992). A self-complete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire. American Journal of Respiratory and Critical Care Medicine, 145, 1321–1327. Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992). A self-complete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire. American Journal of Respiratory and Critical Care Medicine, 145, 1321–1327.
9.
go back to reference Padilla, A., Olveira, G., Olveira, C., et al. (2007). Validity and reliability of the St George’s Respiratory Questionnaire in adults with cystic fibrosis. Archivos de Bronconeumologia, 43, 205–211. PubMedCrossRef Padilla, A., Olveira, G., Olveira, C., et al. (2007). Validity and reliability of the St George’s Respiratory Questionnaire in adults with cystic fibrosis. Archivos de Bronconeumologia, 43, 205–211. PubMedCrossRef
10.
go back to reference Martínez-García, M. A., Perpiñá Tordera, M., Román Sánchez, P., & Soler Cataluña, J. J. (2005). Internal consistency and validity of the Spanish version of the St. George’s respiratory questionnaire for use in patients with clinically stable bronchiectasis. Archivos de Bronconeumologia, 41, 110–117. PubMed Martínez-García, M. A., Perpiñá Tordera, M., Román Sánchez, P., & Soler Cataluña, J. J. (2005). Internal consistency and validity of the Spanish version of the St. George’s respiratory questionnaire for use in patients with clinically stable bronchiectasis. Archivos de Bronconeumologia, 41, 110–117. PubMed
11.
go back to reference Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., et al. (2009). Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest Journal, 135, 1223–1232. CrossRef Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., et al. (2009). Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest Journal, 135, 1223–1232. CrossRef
12.
go back to reference Martínez-García, M. A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J. J. (2005). Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest Journal, 128, 739–745. CrossRef Martínez-García, M. A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J. J. (2005). Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest Journal, 128, 739–745. CrossRef
13.
go back to reference Wilson, C. B., Jones, P. W., O’Leary, C. J., Hansell, D. M., Cole, P. J., & Wilson, R. (1997). Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. European Respiratory Journal, 10, 1754–1760. PubMedCrossRef Wilson, C. B., Jones, P. W., O’Leary, C. J., Hansell, D. M., Cole, P. J., & Wilson, R. (1997). Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. European Respiratory Journal, 10, 1754–1760. PubMedCrossRef
14.
go back to reference Chan, S. L., Chan-Yeung, M. M., Ooi, G. C., et al. (2002). Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest Journal, 122, 2030–2037. CrossRef Chan, S. L., Chan-Yeung, M. M., Ooi, G. C., et al. (2002). Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest Journal, 122, 2030–2037. CrossRef
15.
go back to reference Jones, P. W. (2002). Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal, 19, 398–404. PubMedCrossRef Jones, P. W. (2002). Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal, 19, 398–404. PubMedCrossRef
16.
go back to reference Martínez-García, M. A., Soler-Cataluña, J. J., Catalán-Serra, P., Román-Sánchez, P., & Tordera, M. P. (2012). Clinical efficacy and safety of budesonide formoterol in non-cystic fibrosis BQ. Chest Journal, 141, 461–468. CrossRef Martínez-García, M. A., Soler-Cataluña, J. J., Catalán-Serra, P., Román-Sánchez, P., & Tordera, M. P. (2012). Clinical efficacy and safety of budesonide formoterol in non-cystic fibrosis BQ. Chest Journal, 141, 461–468. CrossRef
17.
go back to reference Murray, M. P., Turnbull, K., Mac Quarrie, S., Pentland, J. L., & Hill, A. T. (2009). Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. European Respiratory Journal, 34, 125–131. PubMedCrossRef Murray, M. P., Turnbull, K., Mac Quarrie, S., Pentland, J. L., & Hill, A. T. (2009). Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. European Respiratory Journal, 34, 125–131. PubMedCrossRef
18.
go back to reference Reda, A. A., Kotz, D., Kocks, J. W., Wesseling, G., & Van Schayck, C. P. (2010). Reliability and validity of the clinical COPD questionnaire and chronic respiratory questionnaire. Respiratory Medicine, 104, 1675–1682. PubMedCrossRef Reda, A. A., Kotz, D., Kocks, J. W., Wesseling, G., & Van Schayck, C. P. (2010). Reliability and validity of the clinical COPD questionnaire and chronic respiratory questionnaire. Respiratory Medicine, 104, 1675–1682. PubMedCrossRef
19.
go back to reference Quittner, A. L., Cruz, I., Marciel, K. K., Ilowite, J., Gotfried, M. H., & Barker, A. (2009). A new PRO for non-CF bronchiectasis: Associations between the QOL-B and health outcomes. [Abstract]. European Respiratory Journal, 34(Suppl. 53), 1010. Quittner, A. L., Cruz, I., Marciel, K. K., Ilowite, J., Gotfried, M. H., & Barker, A. (2009). A new PRO for non-CF bronchiectasis: Associations between the QOL-B and health outcomes. [Abstract]. European Respiratory Journal, 34(Suppl. 53), 1010.
20.
go back to reference Quittner, A. L., Salathe, M., Gotfried, M., et al. (2010). National validation of a patient-reported outcome measure for bronchiectasis: Psychometric results on the QOL-B.[Abst.] American Journal of Respiratory Critical Care Medicine A5793. www.​atsjournals.​org Online Abstracts Issue. Quittner, A. L., Salathe, M., Gotfried, M., et al. (2010). National validation of a patient-reported outcome measure for bronchiectasis: Psychometric results on the QOL-B.[Abst.] American Journal of Respiratory Critical Care Medicine A5793. www.​atsjournals.​org Online Abstracts Issue.
21.
go back to reference Quittner, A. L. (2012). Development of a disease-specific PRO for non-CF bronchiectasis: The QOL-B FDA Workshop 2012. Quittner, A. L. (2012). Development of a disease-specific PRO for non-CF bronchiectasis: The QOL-B FDA Workshop 2012.
22.
go back to reference Naidich, D. P., McCauley, D. I., Khouri, N. F., Stitik, F. P., & Siegelman, S. S. (1982). Computed tomography of bronchiectasis. Journal of Computer Assisted Tomography, 6, 437–444. PubMedCrossRef Naidich, D. P., McCauley, D. I., Khouri, N. F., Stitik, F. P., & Siegelman, S. S. (1982). Computed tomography of bronchiectasis. Journal of Computer Assisted Tomography, 6, 437–444. PubMedCrossRef
23.
go back to reference Rosenstein, B. J., & Cutting, G. R. (1998). The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. Journal of Pediatrics, 132, 589–595. PubMedCrossRef Rosenstein, B. J., & Cutting, G. R. (1998). The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. Journal of Pediatrics, 132, 589–595. PubMedCrossRef
24.
go back to reference Medical Research Council. (1982). Committee on research into chronic bronchitis: Instruction for use on the questionnaire on respiratory symptoms. In S. M. Brooks (Ed.), Surveillance for respiratory hazards (Vol. 8, pp. 12–16). ATS News. Devon: WJ Holman 1966. Medical Research Council. (1982). Committee on research into chronic bronchitis: Instruction for use on the questionnaire on respiratory symptoms. In S. M. Brooks (Ed.), Surveillance for respiratory hazards (Vol. 8, pp. 12–16). ATS News. Devon: WJ Holman 1966.
25.
go back to reference Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease, 40, 373–383. CrossRef Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease, 40, 373–383. CrossRef
26.
go back to reference Roca, J., Sanchis, J., Agustí Vidal, A., et al. (1986). Spirometric reference values for a Mediterranean population. Bulletin Européen de Physiopathologie Respiratoire, 22, 217–224. PubMed Roca, J., Sanchis, J., Agustí Vidal, A., et al. (1986). Spirometric reference values for a Mediterranean population. Bulletin Européen de Physiopathologie Respiratoire, 22, 217–224. PubMed
27.
go back to reference Bhalla, M., Turcios, N., Aponte, V., et al. (1991). Cystic fibrosis: Scoring system with thin-section CT. Radiology, 179, 783–788. PubMed Bhalla, M., Turcios, N., Aponte, V., et al. (1991). Cystic fibrosis: Scoring system with thin-section CT. Radiology, 179, 783–788. PubMed
28.
go back to reference Snider, G. L., Kory, R. C., & Lyons, H. A. (1967). Grading of pulmonary function impairment by means of pulmonary function test. Diseases of the Chest, 52, 270–271. CrossRef Snider, G. L., Kory, R. C., & Lyons, H. A. (1967). Grading of pulmonary function impairment by means of pulmonary function test. Diseases of the Chest, 52, 270–271. CrossRef
29.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum Associates.
30.
go back to reference Quittner, A. L., Avani Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, B. (2009). Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest Journal, 135, 1610–1618. CrossRef Quittner, A. L., Avani Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, B. (2009). Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest Journal, 135, 1610–1618. CrossRef
31.
go back to reference Quittner, A. L., Sawicki, G. S., Mc Mulen, A., et al. (2012). Psychometric evaluation of the Cystic Fibrosis Questionnaire-revised in a national US simple. Quality of Life Research, 21, 1279–1290. PubMedCrossRef Quittner, A. L., Sawicki, G. S., Mc Mulen, A., et al. (2012). Psychometric evaluation of the Cystic Fibrosis Questionnaire-revised in a national US simple. Quality of Life Research, 21, 1279–1290. PubMedCrossRef
32.
go back to reference Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009). Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R. Health and Quality of Life Outcomes, 7, 97. PubMedCentralPubMedCrossRef Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009). Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R. Health and Quality of Life Outcomes, 7, 97. PubMedCentralPubMedCrossRef
33.
go back to reference Bregnballe, V., Thastum, M., Lund, L., Hansen, C. R., Preissler, T., & Schiøtz, P. O. (2008). Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). Journal of Cystic Fibrosis, 7, 531–536. PubMedCrossRef Bregnballe, V., Thastum, M., Lund, L., Hansen, C. R., Preissler, T., & Schiøtz, P. O. (2008). Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). Journal of Cystic Fibrosis, 7, 531–536. PubMedCrossRef
34.
go back to reference Wilson, C. B., Jones, P. W., O’Leary, C. J., Cole, P. J., & Wilson, R. (1997). Validation of the St George’s Respiratory Questionnaire in bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 156, 536–541. PubMedCrossRef Wilson, C. B., Jones, P. W., O’Leary, C. J., Cole, P. J., & Wilson, R. (1997). Validation of the St George’s Respiratory Questionnaire in bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 156, 536–541. PubMedCrossRef
35.
go back to reference Olveira, G., Olveira, C., Gaspar, I., et al. (2011). Malnutrition and inflammation in patients with bronchiectasis. Clinical Nutrition, 6(suppl 1), 150–151. Olveira, G., Olveira, C., Gaspar, I., et al. (2011). Malnutrition and inflammation in patients with bronchiectasis. Clinical Nutrition, 6(suppl 1), 150–151.
36.
go back to reference Olveira, G., Olveira, C., Gaspar, I., et al. (2012). Fat-free mass depletion and inflammation in patients with bronchiectasis. Journal of the Academy of Nutrition and Dietetics, 112, 1999–2006. PubMedCrossRef Olveira, G., Olveira, C., Gaspar, I., et al. (2012). Fat-free mass depletion and inflammation in patients with bronchiectasis. Journal of the Academy of Nutrition and Dietetics, 112, 1999–2006. PubMedCrossRef
37.
go back to reference Olveira, G., Olveira, C., Dorado, A., et al. (2013). Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis. Clinical Nutrition, 32, 112–117. PubMedCrossRef Olveira, G., Olveira, C., Dorado, A., et al. (2013). Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis. Clinical Nutrition, 32, 112–117. PubMedCrossRef
Metagegevens
Titel
Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0
Auteurs
Casilda Olveira
Gabriel Olveira
Francisco Espildora
Rosa-Maria Giron
Gerard Muñoz
Alexandra L. Quittner
Miguel-Angel Martinez-Garcia
Publicatiedatum
01-05-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0560-0